elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q54383333-5A429A7D-2058-4FBC-A608-B7918661FFB6
Q54383333-5A429A7D-2058-4FBC-A608-B7918661FFB6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q54383333-5A429A7D-2058-4FBC-A608-B7918661FFB6
Combined inhibition of morphogen pathways demonstrates additive antifibrotic effects and improved tolerability.
P2860
Q54383333-5A429A7D-2058-4FBC-A608-B7918661FFB6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q54383333-5A429A7D-2058-4FBC-A608-B7918661FFB6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
67df6e4d27fc1ab0379e2d8aceaaebdfb608ec21
P2860
Morphogen pathways as molecular targets for the treatment of fibrosis in systemic sclerosis.